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Summary
Background—Quantification of the disease burden caused by different risks informs prevention
by providing an account of health loss different to that provided by a disease-by-disease analysis.
No complete revision of global disease burden caused by risk factors has been done since a
comparative risk assessment in 2000, and no previous analysis has assessed changes in burden
attributable to risk factors over time.
Methods—We estimated deaths and disability-adjusted life years (DALYs; sum of years lived
with disability [YLD] and years of life lost [YLL]) attributable to the independent effects of 67
risk factors and clusters of risk factors for 21 regions in 1990 and 2010. We estimated exposure
distributions for each year, region, sex, and age group, and relative risks per unit of exposure by
systematically reviewing and synthesising published and unpublished data. We used these
estimates, together with estimates of cause-specific deaths and DALYs from the Global Burden of
Disease Study 2010, to calculate the burden attributable to each risk factor exposure compared
with the theoretical-minimum-risk exposure. We incorporated uncertainty in disease burden,
relative risks, and exposures into our estimates of attributable burden.
Findings—In 2010, the three leading risk factors for global disease burden were high blood
pressure (7·0% [95% uncertainty interval 6·2–7·7] of global DALYs), tobacco smoking including
second-hand smoke (6·3% [5·5–7·0]), and alcohol use (5·5% [5·0–5·9]). In 1990, the leading risks
were childhood underweight (7·9% [6·8–9·4]), household air pollution from solid fuels (HAP;
7·0% [5·6–8·3]), and tobacco smoking including second-hand smoke (6·1% [5·4–6·8]). Dietary
risk factors and physical inactivity collectively accounted for 10·0% (95% UI 9·2–10·8) of global
DALYs in 2010, with the most prominent dietary risks being diets low in fruits and those high in
sodium. Several risks that primarily affect childhood communicable diseases, including
unimproved water and sanitation and childhood micronutrient deficiencies, fell in rank between





CJLM, SSL, and ME wrote the first draft. SSL, TV, AF, GD, KS, ADL, CJLM, and ME revised the report. ME, CJLM, and ADL
designed the study and provided overall guidance. SSL, EC, GF, CA, ESa, KA, REE, and LCR did comparative analyses of risk
factors. All other authors developed the estimates of risk-specific exposure, theoretical-minimum-risk exposure distribution, and RR
inputs, and checked and interpreted results.
NIH Public Access
Author Manuscript
Lancet. Author manuscript; available in PMC 2014 September 05.
Published in final edited form as:






















1990 and 2010, with unimproved water we and sanitation accounting for 0·9% (0·4–1·6) of global
DALYs in 2010. However, in most of sub-Saharan Africa childhood underweight, HAP, and non-
exclusive and discontinued breastfeeding were the leading risks in 2010, while HAP was the
leading risk in south Asia. The leading risk factor in Eastern Europe, most of Latin America, and
southern sub-Saharan Africa in 2010 was alcohol use; in most of Asia, North Africa and Middle
East, and central Europe it was high blood pressure. Despite declines, tobacco smoking including
second-hand smoke remained the leading risk in high-income north America and western Europe.
High body-mass index has increased globally and it is the leading risk in Australasia and southern
Latin America, and also ranks high in other high-income regions, North Africa and Middle East,
and Oceania.
Interpretation—Worldwide, the contribution of different risk factors to disease burden has
changed substantially, with a shift away from risks for communicable diseases in children towards
those for non-communicable diseases in adults. These changes are related to the ageing
population, decreased mortality among children younger than 5 years, changes in cause-of-death
composition, and changes in risk factor exposures. New evidence has led to changes in the
magnitude of key risks including unimproved water and sanitation, vitamin A and zinc
deficiencies, and ambient particulate matter pollution. The extent to which the epidemiological
shift has occurred and what the leading risks currently are varies greatly across regions. In much
of sub-Saharan Africa, the leading risks are still those associated with poverty and those that affect
children.
Funding—Bill & Melinda Gates Foundation.
Introduction
Measurement of the burden of diseases and injuries is a crucial input into health policy.
Equally as important, is a comparative assessment of the contribution of potentially
modifiable risk factors for these diseases and injuries. The attribution of disease burden to
various risk factors provides a different account compared with disease-by-disease analysis
of the key drivers of patterns and trends in health. It is essential for informing prevention of
disease and injury.
Understanding the contribution of risk factors to disease burden has motivated several
comparative studies in the past few decades. The seminal work of Doll and Peto1 provided a
comparative assessment of the importance of different exposures, particularly tobacco
smoking, in causing cancer. Peto and colleagues2 subsequently estimated the effects of
tobacco smoking on mortality in developed countries since 1950. Although these risk factor-
specific or cause-specific analyses are useful for policy, a more comprehensive global
assessment of burden of disease attributable to risk factors can strengthen the basis for
action to reduce disease burden and promote health. The Global Burden of Disease Study
(GBD) 1990 provided the first global and regional comparative assessment of mortality and
disability adjusted life-years (DALYs) attributable to ten major risk factors.3 However,
different epidemiological traditions for different risks limited the comparability of the
results. Subsequently, Murray and Lopez4 proposed a framework for global comparative risk
assessment, which laid the basis for assessment of 26 risks in 2000.5–7 Since this work,
WHO has provided estimates for some risks by the same methods but with updated
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exposures and some updates of the effect sizes for each risk.8 Analyses have also been done
for specific clusters of diseases, like cancers,9 or clusters of risk factors, like maternal and
child under-nutrition.10 National comparative risk assessments (including in Australia, Iran,
Japan, Mexico, South Africa, Thailand, USA, and Vietnam) have also been undertaken with
similar approaches.11–16
GBD 2010 provides an opportunity to re-assess the evidence for exposure and effect sizes of
risks for a broad set of risk factors by use of a common framework and methods.
Particularly, since this work was done in parallel with a complete re-assessment of the
burden of diseases and injuries in 1990 and 2010, for the first time changes in burden of
disease attributable to different risk factors can be analysed over time with comparable
methods. Since uncertainty has been estimated for each disease or injury outcome,17,18 the
comparative risk assessment for GBD 2010 has also enabled us to incorporate uncertainty
into the final estimates. We describe the general approach and high-level findings for
comparison of the importance of 67 risk factors and clusters of risk factors, globally and for
21 regions of the world, over the past two decades.
Methods
Overview
The basic approach for the GBD 2010 comparative risk assessment is to calculate the
proportion of deaths or disease burden caused by specific risk factors—eg, ischaemic heart
disease caused by increased blood pressure—holding other independent factors unchanged.
These calculations were done for 20 age groups, both sexes, and 187 countries and for 1990,
2005 (results for 2005 not shown, available from authors on request), and 2010. We present
aggregated results for 21 regions.
Table 1 shows the included risk factors and their organisation into a hierarchy with three
levels. Level 1 risks are clusters of risk factors that are related by mechanism, biology, or
potential policy intervention. Most risks are presented at level 2. For occupational
carcinogens, a third level is included to provide additional detail about specific carcinogens.
For suboptimal breastfeeding we also include a third level to distinguish between
nonexclusive breastfeeding during the first 6 months and discontinued breastfeeding from 6
to 23 months.
We calculated burden attributable to all (67) risk factors and clusters of risk factors except
for physiological risks and air pollution. These two clusters present analytical challenges for
computation of the aggregate burden. For example, the effects of high body-mass index are
partly mediated through high blood pressure, high total cholesterol, and high fasting plasma
glucose, and household air pollution from solid fuels (wood, crop, residues, animal dung,
charcoal, and coal) contributes to ambient particulate matter pollution.
We ranked results for 43 risk factors and clusters of risk factors, grouping together
occupational carcinogens, non-exclusive and discontinued breastfeeding, and tobacco
smoking with second-hand smoke on the basis of common exposure sources.
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Our estimation of disease burden attributable to a risk factor had five steps: 1) selection of
risk–outcome pairs to be included in the analysis based on criteria about causal associations;
2) estimation of distributions of exposure to each risk factor in the population; 3) estimation
of etiological effect sizes, often relative risk per unit of exposure for each risk–outcome pair;
4) choice of an alternative (counterfactual) exposure distribution to which the current
exposure distribution is compared. We selected an optimum exposure distribution, termed
the theoretical-minimum-risk exposure distribution for this purpose; and 5) computation of
burden attributable to each risk factor, including uncertainty from all sources. Further details
about the data and methods used for specific risk factors are available on request.
Selection of risk–outcome pairs
The inclusion criteria for each risk–outcome pair that we applied were: 1) the likely
importance of a risk factor to disease burden or policy based on previous work; 2)
availability of sufficient data and methods to enable estimation of exposure distributions by
country for at least one of the study periods (1990 and 2010); 3) sufficient evidence for
causal effects based on high-quality epidemiological studies in which the findings were
unlikely to be caused by bias or chance, analogous to the criteria used for assessment of
carcinogens with con vincing or probable evidence (panel). Sufficient data to estimate
outcome-specific etiological effect sizes per unit of exposure were also needed; and 4)
evidence to support generalisability of effect sizes to populations other than those included
in the available epidemiological studies or satisfactory models for extrapolating them. Table
1 shows the risk–outcome pairs that were included in the final analysis, on the basis of these
criteria.
Distribution of exposure to each risk factor
For most risk factors, a systematic search was done to identify published and, when possible,
unpublished data sources to estimate risk factor exposure distributions in 1990 and 2010.
Strategies to identify data sources included searching survey databases such as the WHO
Global Database on Child Growth and Malnutrition, searching general citation databases
such as Google Scholar and PubMed, manual searching of reference lists of articles and
conference abstracts, and contacting experts in the relevant fields. Data sources included
censuses, health examination and nutrition surveys, and community-based epidemiological
studies.
Because data for risk factor exposure are often incomplete or missing for many populations,
models were used to generate a complete set of current exposure distributions for risk
factors for each country and for both years, including uncertainty. Table 1 shows for each
risk factor the main sources of data and the modelling approach used for estimation of
present risk factor exposure distributions. Briefly, risk factor models were designed to use
available data and information for exposures in countries, for several years, and for different
age groups to generate estimates for all countries, for both years, and for all relevant age
groups. Estimation of exposure was done with statistical models that used predictors such as
time, geography, and other variables that were relevant to the exposure of interest— eg,
income per person.
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For each risk factor, we tested a wide array of covariates for prediction of exposure
distributions, drawing from covariates included in databases created or collated at the
Institute for Health Metrics and Evaluation for GBD 2010. If relevant, the model also
included age. Finally, each analysis accounted for important study characteristics such as
national versus subnational representativeness, and the measures and instruments used for
measuring exposure.
In addition to this general approach, specific methods were used for some risk factors. For
tobacco including second-hand smoke, much scientific literature exists about alternative
methods to estimate cumulative exposure, based on the premise that present prevalence and
consumption data do not take into account likely variations in duration and intensity of
smoking. In this case, we used the method of Peto and Lopez,2 which uses lung cancer
mortality as a marker (ie, smoking impact ratio) of cumulative population exposure to
smoking for cancers and chronic respiratory disease. We used epidemiological data to
estimate lung cancer mortality in non-smokers separately for China, other countries in the
high-income Asia Pacific region, and all remaining countries.119,120 For all other outcomes,
we used 10-year lagged tobacco smoking prevalence. We also applied an approach
analogous to the smoking impact ratio for occupational exposure to asbestos, for which we
used mesothelioma mortality, separately estimated, as a marker of asbestos exposure.
For ambient particulate matter pollution, two complete, high resolution estimates exist of the
concentration of particulate matter smaller than 2·5 µm in aerodynamic diameter (PM2·5) in
ambient air: TM5 estimates—based on a nested three-dimensional global atmospheric
chemistry transport model—which simulates both particulate matter and ozone at a high
spatial resolution;22,23,121 and satellite-based estimates, which are based on satellite
observations of aerosol optical depth, a measure of light extinction by aerosols in the total
atmospheric column.25 TM5 and satellite-based estimates of PM2·5, measured in µg/m3,
were averaged at a 0·1° × 0·1° grid cell resolution (equivalent to roughly 11 km × 11 km at
the equator) and linked to available measures of PM2·5 from ground-based monitors. We
used a regression model with the average of TM5 and satellite-based estimates as the
predictor to estimate ground-based PM2·5 for all grid cells.26 For ozone, we relied solely on
the TM5 model.
Few population-based surveys have measured zinc deficiency based on serum zinc
concentration;122 however, intervention trials show a benefit of zinc supplementation for
reduction of diarrhoea and lower respiratory infections in populations that have high zinc
deficiency.10 Because of the paucity of data for serum zinc concentrations, we measured
zinc deficiency at the population level on the basis of dietary sources of zinc, expanding on
previous work of the International Zinc Nutrition Consultative Group.123 This approach uses
national food balance sheets produced by the UN Food and Agriculture Organization to
estimate a country-specific mean fractional absorption of zinc. The estimated mean daily per
person amount of absorbable zinc in the food supply was compared with the mean
physiological requirements of the population to calculate the percentage of the population
with inadequate zinc intake.
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Effects of risk factors on disease outcomes
Table 1 shows the sources of effect sizes per unit of exposure for each risk factor. Some
effect sizes were based on meta-analyses of epidemiological studies. For several risk factors
without recent systematic reviews or for which evidence had not recently been synthesised,
new meta-analyses were done as part of GBD 2010. We used effect sizes that had been
adjusted for measured confounders but not for factors along the causal pathway. For
example, effect sizes for body-mass index were not adjusted for blood pressure. For some
risk–outcome pairs, evidence is only available for the relative risk (RR) of morbidity or
mortality. In these cases, we assumed that the reported RR would apply equally to morbidity
or mortality, unless evidence suggested a differential effect. For example, studies of ambient
particulate matter pollution suggest a smaller effect on incidence of cardio vascular and
respiratory disease than on mortality;124–126 the published work on consumption of seafood
omega-3 fatty acids suggests an effect on ischaemic heart disease mortality but not on
incidence of ischaemic heart disease.90
Evidence for the RR of diarrhoea from unimproved water and sanitation is complicated by
the complexity of available epidemiological studies, since the comparison groups varied
greatly between studies. The comparison group used varied widely. For example, some
studies compare an improved water source (eg, piped water) with an unimproved water
source (eg, river water); in other studies the comparison is between two different types of
improved water source (eg, piped water vs a protected well). Furthermore, studies often
examine a combination of water, sanitation, and hygiene interventions. Previous reviews
have yielded conflicting results about the magnitude of the effect sizes.127–131
We re-examined the epidemiological evidence for the effects of water and sanitation by
reviewing the relation between water, sanitation and hygiene, and diarrhoea, starting with
previous reviews.128–131 We did a meta-regression of 119 studies that was designed to
adjust for intervention and baseline group characteristics. First, we compared indicator
variables for each of the intervention components (improved sanitation, hygiene, point-of-
use water treatment, source water treatment, and piped water) with a reference category
(improved water source). Second, we also included indicator variables for the baseline
characteristics—ie, whether the baseline was an unimproved or improved water source or
sanitation—as covariates to account for the heterogeneous control groups. Our analysis
showed a significant effect of both improved water and improved sanitation compared with
unimproved water and sanitation; we did not note a significantly greater effect of piped
water or point-of-use or source water treatment compared with improved water.
Particulate matter smaller than 2·5 µm is a common useful indicator of the risk associated
with exposure to a mixture of pollutants from diverse sources and in different environments,
including ambient particulate matter pollution from transportation, wind-blown dust,
burning of bio mass, and industrial sources; second-hand smoke; burning of biomass and
coal for household energy; and active smoking.132,133 However, existing studies cover only
small concentration ranges—for example, ambient particulate matter pollution studies have
been restricted to yearly average concentrations of particulate matter smaller than 2·5 µm of
roughly 5 µg/m3 to 30 µg/m3,134–137 but much higher concentrations of ambient particulate
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matter have been recorded in polluted cities in Asia and elsewhere. The relation between
concentration of small particulate matter and risk of disease is probably non-linear.132,133
To inform estimates of risk across the full range of concentrations, we used the approach of
Pope and colleagues132 and integrated epidemiological evidence for the hazardous effects of
particulate matter at different concentrations from different sources and environments.
Methods for estimation of the integrated exposure– response curves for each cause are
described elsewhere.138 Briefly, we compiled study-level estimates of the RR of mortality
associated with any or all of ambient air pollution, second-hand smoke, household air
pollution, and active smoking for the following outcomes: ischaemic heart disease, stroke,
lung cancer, chronic obstructive pulmonary disease, and acute lower respiratory tract
infection in children. We evaluated several non-linear functions with up to three parameters
for fitting the integrated exposure– response relation and assessed them by calculation of the
root mean squared error. An exponential decay with a power of concentration was the
functional form that provided the best fit for all five outcomes. The integrated exposure–
response curve was then used to generate effect sizes specific to the amount of ambient
particulate matter smaller than 2·5 µm for each population. For ischaemic heart disease and
stroke, evidence shows that household air pollution affects intermediate outcomes, such as
blood pressure,139 but not clinical events. For acute lower respiratory tract infection, the
integrated exposure– response curve enabled us to extrapolate beyond the partial exposure–
response measured in the RESPIRE trial.140 For effects of household air pollution on
chronic obstructive pulmonary disease and lung cancer we use the effect size based on new
systematic reviews and meta-analyses.
Several dietary factors affect ischaemic heart disease and stroke, including consumption of
fruits, vegetables, nuts and seeds, whole grains, processed meat, polyunsaturated fats, and
seafood omega-3 fatty acids.81,83,85,87,90–92,141,142 We updated earlier systematic reviews
and meta-analyses for fruits, vegetables, and seafood omega-3 fatty acids, which included
both observational and intervention studies if available. A systematic review143 of
randomised clinical trials of supplementation with seafood omega-3 fatty acids reported
non-significant effects on several outcomes, and a significant effect for mortality from
ischaemic heart disease—the primary outcome in GBD 2010. In view of this finding, we
tested whether a significant difference exists between the randomised clinical trials of
seafood omega-3 fatty acid supplementation and observational studies of seafood-omega 3
fatty acid intake. The effect of seafood omega-3 fatty acids tended to be lower in
randomised controlled trials than in observational studies, however, this difference was not
statistically significant (p=0·057). Therefore, we used the effect size based on the
combination of randomised clinical trials and observational studies but also did a sensitivity
analysis with the effect size based on randomised clinical trials.
Estimates of the RR associated with dietary risk factors are based largely on observational
studies that control for age, sex, and other cardiovascular risk factors. However, some early
observational studies do not fully control for other dietary components. Protective dietary
risk factors such as consumption of fruits, vegetables, and whole grains, tend to be positively
correlated with each other and negatively correlated with harmful dietary risk factors such as
consumption of processed meat. Therefore, RRs estimated for single risk factors in
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observational studies could overestimate the protective or harmful effect of that risk factor.
In effect, the partially adjusted RR will include some of the effects associated with other
correlated diet components, particularly since the exposure measure for dietary risk factors
is energy adjusted to a standard calorie intake.
To examine this issue, we did further empirical assessments using studies of dietary patterns
and randomised controlled feeding studies. Studies of dietary patterns144–148 have estimated
the effects of beneficial diets (prudent or Mediterranean diets) and harmful diets (western
diets); these studies capture the overall effects of differences in dietary components. For
example, a prudent diet has lots of fruits, vegetables, fish, and whole grains. For each of the
dietary pattern studies we computed the estimated RR for dietary pattern groups with the
RRs from the meta-analyses of single dietary risk factors, the reported differences in dietary
intake, and assuming a multiplicative relation between RRs for individual components.
Results of this internal validation study show that overall, estimation of the effect of dietary
pattern based on the RRs reported for single risk factors was much the same as the effect
reported in the study; across four large cohort studies of seven dietary patterns the average
ratio for the estimated RR reduction compared with the measured RR reduction was 0·98.
In addition to the dietary pattern studies, we also investigated the evidence for the effects of
dietary risk factors from randomised controlled feeding studies, such as DASH149 and
OmniHeart,150 which measured the effect of dietary changes on blood pressure and LDL
cholesterol. We used meta-regression to estimate the pooled effect of fruits, vegetables, nuts
and seeds, whole grains, fish, and dietary fibre on systolic blood pressure and LDL
cholesterol, based on all randomised controlled feeding studies (six treatment groups from
three studies for blood pressure and six treatment groups from two studies for cholesterol).
When translated into an effect using the RRs of blood pressure and cholesterol for ischaemic
heart disease, the average ratio of the estimated to measured RR reduction was 1·07 for all
components and 0·85 when excluding fish, which has mechanisms additional to lowering
blood pressure and cholesterol.151 These two supplementary analyses suggest that the RRs
estimated in the meta-analyses of single dietary risk factors are unlikely to be significantly
biased because of residual confounding due to other diet components.
Pooled epidemiological studies of cardiovascular disease risks show that the RR decreases
with age, and that the inverse age association is roughly log-linear. Based on a pooled
analysis of several risk factors (high blood pressure, high fasting plasma glucose, high total
cholesterol, and tobacco smoking), the age at which the RR reaches 1 is often between 100
and 120 years. We therefore estimated age-specific RRs for all cardiovascular risk factors by
meta-regression of available data with logRR as the dependent variable and median age at
event as the independent variable with an age intercept (RR=1) at age 110 years. Uncertainty
in the RR was generated by simulation analyses.152
The causal association between a risk factor and a disease outcome is often informed by a
wider body of evidence than epidemiological studies of RRs for specific measures of
exposure, especially when disease-specific and age-specific RRs are needed. For example,
although smoking is an established cause of cardiovascular diseases, when cohorts are
analysed in fine age groups, the 95% CI for the effect of smoking on stroke spans 1·0 in
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several age groups.38 Similarly, randomised trials of zinc supplementation were designed to
detect effects on total mortality.36,153 Re-analysis of the same trials for disease-specific
outcomes, which is necessary to extrapo late effects to populations with different causes of
death, reduced their statistical power and gave 95% CIs that spanned 1·0. To use the broad
evidence while accounting for the uncertainty of the subgroup RRs, we included in the
uncertainty analysis all draws of the RR distribution, including those that show a protective
effect as long as the overall relation for the risk factor across all ages is significant. In other
cases, if there are different degrees of exposure for a risk factor, in some exposure categories
the RR might not be significant. We have included draws from these posterior distributions
if the mean values show a dose–response relation. To fairly represent the extent of our
epidemiological knowledge, we have included in the uncertainty analysis draws from the
posterior distribution for those exposure categories that show a protective effect.
Theoretical-minimum-risk exposure distributions for counterfactual comparison
In the comparative risk assessment framework, disease burden attributable to risk factors is
calculated with reference to an alternative (counterfactual) distribution of exposure; in GBD
2010, we used an optimal exposure distribution (in terms of effect on population health),
termed the theoretical-minimum-risk exposure distribution. For several risk factors, such as
tobacco smoking, the choice of theoretical-minimum-risk exposure distribution is clear—ie,
100% of the population being lifelong non-smokers. However, for many of the other risk
factors zero exposure is not possible (eg, blood pressure), or the lowest amount of exposure
that is still beneficial is not yet established. In these cases the theoretical-minimum-risk
exposure distribution was informed by two considerations: the availability of convincing
evidence from epidemiological studies that support a continuous reduction in risk of disease
to the chosen distribution; and a distribution that is theoretically possible at the population
level (table 1).
For some risk factors, new evidence has resulted in a revision of the theoretical-minimum-
risk exposure distribution compared to the previous comparative risk assessment. For
example, the previous distribution for systolic blood pressure was a mean of 115 mm Hg
(SD 6).6 However, subsequent randomised trials154 of blood pressure-lowering medication
suggest that the benefits of lowering blood pressure could continue to 110 mm Hg or lower.
On this basis, we changed the theoretical-minimum-risk exposure distribution to a mean of
110–115 mm Hg (SD 6). For other exposures, the distribution was increased because of data
from new epidemiological studies75— eg, for mean body-mass index we used 21–23 kg/m2,
compared with 21 kg/m2 used previously.
For ambient particulate matter pollution, we did a sensitivity analysis with an alternative
theoretical-minimum-risk exposure distribution that included the effect of regional dust
particulate matter. We did so because although particulate exposure from dust could
theoretically be reduced, it would probably be prohibitively expensive and could only be
done over a very long period. This factor is particularly relevant in areas with high amounts
of dust—eg, deserts. Dusty grid cells were identified as those with an ambient air
concentration of PM2·5 of 36 µg/m3 or more and where the dust fraction from the TM5
chemical transport model was 50% or more.
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Mortality and disease burden attributable to individual and clusters of risk factors
We calculated the burden attributable to risk factors with continuous exposure by comparing
the present distribution of exposure to the theoretical-minimum-risk exposure distribution
for each age group, sex, year (1990 and 2010), and cause according to the following
formula:
Where PAF is the population attributable fraction (burden attributable to risk factor), RR(×)
is the RR at exposure level ×, P1(×) is the (measured or estimated) population distribution of
exposure, P2(×) is the counterfactual distribution of exposure (ie, the theoretical-minimum-
risk exposure distribution), and m the maxi mum exposure level.4
Burden attributable to categorical exposures was calculated by comparing exposure
categories to a reference category for each age, sex, year, and cause according to the
following formula:
Where RRi is the RR for exposure category i, Pi is the fraction of the population in exposure
category i, and n is the number of exposure categories.4
We calculated the burden attributable to clusters of risk factors by computing the combined
population attributable fraction for risk factors for each age, sex, year, and cause according
to the following formula:
Where r is each individual risk factor, and R is the number of risk factors. This approach
assumes that risk factors are independent—ie, it does not account for mediation, exposure
correlation, or effect size modification that might exist between risk factors in a cluster.155
To represent uncertainty in the estimates we used simulation analysis to take 1000 draws
from the posterior distribution of exposure, RR, and each relevant outcome for each age,
sex, country, year. We accounted for the correlation structure of uncertainty (ie, whether
exposure in a country, age group, and sex is high or low might be related to whether it is
high or low in other subgroups) by use of the same draw of exposure across different
outcomes and the same draw of RR across country, age, and sex subgroups when the RR
does not vary by country, age, or sex. We otherwise assumed that the uncertainties in
exposure, RR, and underlying burden attributable to the outcome were independent.
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We computed the mean deaths and DALYs attributable to each risk factor and risk factor
cluster from the 1000 draws. The 95% uncertainty intervals (95% UI) were calculated as the
2·5th and 97·5th percentiles of the 1000 draws. We also computed the mean rank and 95%
UI for the 43 risk factors included in the ranking list. The mean of the ranks for a risk factor
was not necessarily equivalent to the rank of the mean deaths or mean DALYs attributable
to the risk factor.
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data
interpretation, or writing of the report. The corresponding author had full access to all the
data in the study and had final responsibility for the decision to submit for publication.
Results
Quantification of risk factors in this analysis represents the effects of each individual risk
factor, holding all other independent factors constant. The effects of multiple risk factors are
not a simple addition of the individual effects and are often smaller than their sums,156
especially for cardiovascular diseases, which are affected by several risk factors (eg, table
2). The sum of the individual effects of just the metabolic risk factors at the global level is
121% and the summation of all the risks is greater than 400%.
We estimated global attributable mortality and DALYs with uncertainty for 1990, and 2010,
for each of the 67 risk factors and clusters of risk factors (table 3, 4). The appendix shows
full results by region, year, age, and sex for attributable deaths and DALYs. Because of the
interest in the combined effects of multiple risk factors, we have approximated the joint
effects of clusters of risk factors assuming that risk factors included in each cluster are
independent. However, risk factors included in a cluster are not necessarily independent; for
example, a substantial part of the burden attributable to high body-mass index is mediated
through high blood pressure and high fasting plasma glucose. Others act together and risk
factor exposures might be correlated at the individual level,155 especially household air
pollution and ambient particulate matter pollution, which might have common sources.
For these reasons we have not computed the joint effects for physiological risk factors or air
pollution. However, the combined effects of physiological risk factors are probably large,
with high blood pressure the leading single risk factor globally, accounting for 9·4 million
(95% UI 8·6 million to 10·1 million) deaths and 7·0% (6·2–7·7) of global DALYs in 2010,
followed by high body-mass index (3·4 million [2·8 million to 4·0 million deaths] and 3·8%
[3·1–4·4] of global DALYs in 2010), high fasting plasma glucose (3·4 million [2·9 million to
3·7 million] deaths and 3·6% [3·1–4·0] of DALYs), high total cholesterol (2·0 million [1·6
million to 2·5 million] deaths and 1·6% [1·3–2·0] of DALYs), and low bone mineral density
(0·2 million [0·1 million to 0·2 million] deaths and 0·21% [0·17–0·25] of DALYs).
The joint effects of air pollution are also likely to be large. Household air pollution from
solid fuels accounted for 3·5 million (2·7 million to 4·4 million) deaths and 4·5% (3·4–5·3)
of global DALYs in 2010 and ambient particulate matter pollution accounted for 3·1 million
(2·7 million to 3·5 million) deaths and 3·1% (2·7–3·4) of global DALYs. For ambient
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particulate matter pollution, we also did a post-hoc sensitivity analysis excluding the effects
of dust, which had a small effect worldwide—attributable global DALYs decreased by 2%
—but large effects in north Africa and Middle East. Household air pollution is an important
contributor to ambient particulate matter pollution; we estimate that it accounted for 16% of
the worldwide burden from ambient particulate matter pollution in 2010. The effects of
ambient ozone pollution, which increases the risk of chronic obstructive pulmonary disease,
were smaller than those of household air pollution from solid fuels or ambient particulate
matter pollution (0·2 million [0·1 million to 0·3 million] deaths and 0·1% [0·03–0·2] of
global DALYs in 2010).
For other clusters of risk factors for which we approximated the joint effects assuming
independence, dietary risk factors and physical inactivity were responsible for the largest
disease burden: 10·0% (9·2–10·8) of global DALYs in 2010. Of the individual dietary risk
factors, the largest attributable burden in 2010 was associated with diets low in fruits (4·9
million [3·8 million to 5·9 million] deaths and 4·2% [3·3–5·0] of global DALYs), followed
by diets high in sodium (4·0 million [3·4 million to 4·6 million]; 2·5% [1·7–3·3]), low in nuts
and seeds (2·5 million [1·6 million to 3·2 million]; 2·1% [1·3–2·7]), low in whole grains (1·7
million [1·3 million to 2·1 million]; 1·6% [1·3–1·9]), low in vegetables (1·8 million [1·2
million to 2·3 million]; 1·5% [1·0–2·1]), and low in seafood omega-3 fatty acids (1·4 million
[1·0 million to 1·8 million]; 1·1% [0·8–1·5]). Our sensitivity analysis of omega-3 fatty acids
using relative risks from randomised trials reduced the attributable burden by more than
half, to 0·6 million (–0·6 million to 1·7 million) deaths, and 0·5% (−0·5 to 1·4) of global
DALYs in 2010. Physical inactivity and low physical activity accounted for 3·2 million (2·7
million to 3·7 million) deaths, and 2·8% (2·4–3·2) of DALYs in 2010.
Child and maternal undernutrition was responsible for the next largest attributable burden of
the risk factor clusters (1·4 million [1·2 million to 1·7 million] deaths; 6·7% [5·7–7·7] of
global DALYs in 2010), with childhood underweight the largest individual contributor (0·9
million [0·7 million to 1·0 million]; 3·1% [2·6–3·7]), followed by iron deficiency (0·1
million [0·09 million to 0·14 million]; 1·9% [1·4–2·6]), and suboptimal breast feeding (0·5
million [0·3 million to 0·8 million]; 1·9% [1·2–2·7]). Vitamin A and zinc deficiencies
amongst children accounted for less than 0·8% of the disease burden.
The burdens of disease attributable to tobacco smoking including second-hand smoke (6·3
million [5·4 million to 7·0 million] deaths and 6·3% [5·5–7·0] of DALYs) as well as alcohol
and drug use (5·0 million [4·7 million to 5·3 million] deaths and 6·5% [6·0–7·0] of DALYs)
were substantial in 2010. These burdens are mainly driven by active smoking, which
accounts for 87% of the combined burden with second-hand smoke, and alcohol use which
accounted for 4·9 million (4·5 million to 5·2 million) deaths and 5·5% (5·0–5·9) of global
DALYs in 2010. Of the remaining risk factor clusters, occupational risk factors accounted
for 0·9 million (0·7 million to 1·1 million) deaths and 2·5% (2·0–3·0) of global DALYs in
2010, followed by sexual abuse and violence (0·2 million [0·1 million to 0·3 million] deaths
and 0·9% [0·7–1·2] DALYs), unimproved water and sanitation, (0·3 million [0 to 0·6
million] deaths and 0·9% [0·04–1·6] DALYs), and other environmental risks (0·7 million
[0·6 million to 0·9 million] deaths and 0·6% [0·5–0·8] DALYs).
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The rest of the results section refers to the 43 risk factors and clusters of risk factors in the
rank list. The predominance of non-communicable disease risks in 2010 highlights the
global epidemiological transition that has occurred since 1990 (figures 1, 2, 3). In 1990, the
leading risks were childhood underweight (7·9% [6·8–9·4] of global DALYs), household air
pollution from solid fuels (7·0% [5·6–8·3]), and tobacco smoking including second-hand
smoke (6·1% [5·4–6·8]), high blood pressure (5·5% [4·9–6·0]), and suboptimal breast
feeding (4·4% [2·8–6·1]). With the exception of house hold air pollution, which is a
significant contributor to childhood lower respiratory tract infections, the five leading risk
factors in 2010 (high blood pressure, tobacco smoking including secondhand smoke, alcohol
use, household air pollution, and diets low in fruits) are mainly causes of adult chronic
disease, especially cardio vascular diseases and cancers (figures 1, 2). The burden of disease
attributable to other chronic disease risk factors also increased substantially between 1990
and 2010; for example, the global disease burden attributable to high body-mass index
increased from 52 million to 94 million DALYs and that of high fasting plasma glucose
increased from 56 million to 89 million DALYs over this period.
The rise in global disease burden attributable to chronic disease risk factors has been
accompanied by a decrease in the relative importance of risk factors that largely or
exclusively cause communicable diseases in children. The global disease burden attributable
to childhood underweight halved between 1990 (7·9% [6·8–9·4] of global DALYs) and 2010
(3·1% [2·6–3·7]; table 3). Although the fraction of disease burden attributable to iron
deficiency fell relatively little, suboptimal breastfeeding, unimproved water, unimproved
sanitation, vitamin A deficiency, and zinc deficiency all decreased substantially between
1990, and 2010.
The transition from childhood communicable to non-communicable disease burden is also
exemplified by the fall in DALYs caused by household air pollution from solid fuels
(despite the rise in its effects on cardiovascular diseases). Although the burden attributable
to ambient particulate matter pollution has largely remained unchanged (3·2% [2·8–3·7] of
global DALYs in 1990 vs 3·0% [2·6–3·4] in 2010), the contribution of lower respiratory
tract infections had fallen sharply by 2010, with chronic diseases of adults being the
dominant health outcome caused by this exposure.
Figure 4 shows the 95% uncertainty interval in global DALYs attributable to each risk factor
and the overall rank for each risk factor. The uncertainty intervals for many risk factors
overlap, especially those not in the top five. Unimproved water, unimproved sanitation,
vitamin A deficiency, and zinc deficiency have large uncertainty, which reflects the
substantial uncertainty in the estimates of etiological effect sizes for these risks.
Some risks were quantified for women only—for example, intimate partner violence, which
accounted for 1·5% (1·0—2·1) of DALYs among women in 2010. Important differences
between men and women also exist for disease burden attributable to other risk factors, most
notably, for tobacco smoking including secondhand smoke and alcohol use (figures 1, 2).
These risks cause substantially lower burden in women than in men, because women drink
less and in less harmful ways than do men, and fewer smoke or have smoked for a shorter
time than have men in most regions.157 In 2010, tobacco smoking including second-hand
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smoke accounted for 8·4% of worldwide disease burden among men (the leading risk factor)
compared with 3·7% among women (fourth highest risk factor). For alcohol use, these sex
differences were similarly sub stantial: 7·4% (third) versus 3·0% (eighth). The effect of
occupational risk factors on population health also differed between sexes—for example, the
fraction of disease burden attributable to occupational risk factors for injuries was 18·5 times
higher for men than for women in 2010 (20 175 000 DALYs for men vs 1 090 000 for
women). Dietary risk factors had broadly similar effects for men and women with the
exception of diet low in fruits, for which the fraction of disease burden attributable was 1·5
times larger for men than for women in 2010 (47 979 000 DALYs for men vs 32 474 000 for
women). This effect is caused by lower fruit consumption and a larger disease burden from
cardiovascular disease in men.
Further disaggregation of mortality and disease burden attributable to risk factors reveals
several patterns by age group (appendix). Among children younger than 5 years, childhood
underweight was the leading risk factor worldwide in 2010 (12·4% [10·4–14·7] of global
DALYs), followed by non-exclusive or discontinued breast feeding (7·6% [4·8–10·9]) and
household air pollu tion from solid fuels (6·3% [4·4–8·1]). Vitamin A and zinc deficiencies,
unimproved sanitation, and unimproved water each accounted for less than 2% of disease
burden in children younger than 5 years.
For people aged 15–49 years, the leading risk factor worldwide was alcohol use, followed
by tobacco smoking including second-hand smoke, high blood pressure, high body-mass
index, diet low in fruits, drug use, and occupational risk factors for injuries. Risk factor
rankings in this age group stayed broadly similar between 1990, and 2010, with the
exception of iron deficiency, which dropped from the fourth leading risk factor in 1990, to
ninth in 2010.
High blood pressure, tobacco smoking including second-hand smoke, alcohol use, and diet
low in fruits were all in the top five risk factors for adults aged 50–69 years and adults older
than 70 years, in both 1990, and 2010, accounting for a large proportion of disease burden in
both age groups. Globally, high blood pressure accounted for more than 20% of all health
loss in adults aged 70 years and older in 2010, and around 15% in those aged 50–69 years.
Tobacco smoking including secondhand smoke accounted for more than 10% of global
disease burden in each of these age groups in 2010.
In all 21 regions, and worldwide, a shift has occurred, from risk factors for childhood
communicable disease to risk factors for non-communicable disease. The size of this shift
and which risk factors account for the largest burden varies highly between regions (figure
5, appendix).
In central, eastern, and western sub-Saharan Africa, the share of disease burden attributable
to childhood underweight, household air pollution from solid fuels, and suboptimal
breastfeeding has fallen sub stantially. However, these risk factors continue to be the leading
three causes of disease burden in 2010. The disease burden attributable to risk factors for
childhood communicable diseases, such as micronutrient deficiencies and unimproved water
and sanitation, has decreased, both as a proportion of total disease burden and in their rank
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order: risk factors for some non-communicable diseases and injury accounted for a larger
disease burden in 2010. The most notable of these factors were alcohol use and high blood
pressure (appendix).
Compared with other regions of sub-Saharan Africa, southern sub-Saharan Africa had a
more mixed pattern of risk factor burden in 1990 (appendix). In 2010, alcohol use was the
leading risk factor in southern sub-Saharan Africa, followed by high blood pressure and high
bodymass index (figure 6). In addition to high exposure to harmful alcohol use, the effects
of alcohol were particularly large because it increases the risk of road traffic and other
unintentional and intentional injuries, as well as of tuberculosis,47 all of which are large
causes of disease and injury burden in this region.
In south Asia, the rise of risk factors for non-communicable diseases is shown by the
substantial increase in the burden attributable to tobacco smoking including second-hand
smoke, high blood pressure and other metabolic risk factors, dietary risk factors, and alcohol
use. However, household air pollution from solid fuels was, despite decreases, the leading
risk factor in 2010. Childhood underweight was still the fourth leading risk factor in 2010,
despite its share of disease burden having more than halved from 11·9% [95% UI 10·1–14·4]
of DALYs in 1990, to 4·0% [3·2–4·9] in 2010. Other risk factors for communicable disease,
such as suboptimal breastfeeding and micronutrient deficiencies, fell sub stantially in the
region as child mortality decreased.
In southeast, east, and central Asia, the epidemiological transition was already well
advanced in 1990, and by 2010, high blood pressure (which is commonly associated with
diets high in sodium as a prominent underlying cause94,158), tobacco smoking including
second-hand smoke, and diets low in fruits were all among the five leading risk factors in
these regions. The disease burden attributable to childhood underweight and sub optimal
breastfeeding had been largely eliminated in east Asia by 2010, although they remain
important in southeast Asia. In these three regions, despite decreases, household air
pollution from solid fuels was still a leading risk factor in 2010, ranked third in south-east
Asia, sixth in east Asia, and 12th in central Asia. Ambient particulate matter pollution
accounted for a larger disease burden than did household air pollution in central and east
Asia in 2010, although household solid fuels is an important source of ambient particulate
matter pollution in these regions.
The North Africa and Middle East region also had a large shift from risk factors for
communicable to non-communicable diseases. In 2010, risk factors for noncommunicable
disease almost exclusively dominated the region’s causes of loss of health, with high blood
pressure and high body-mass index each accounting for roughly 8% of disease burden,
followed by tobacco smoking including second-hand smoke, high fasting plasma glucose,
and physical inactivity or low physical activity. Ambient particulate matter pollution
(seventh leading risk factor) is a notable cause of disease burden in this region, caused by a
combination of polluted cities and dust from the Sahara desert.
Alcohol use was an important cause of disease burden in most of Latin America. It was
ranked first in central Latin America, fourth in tropical Latin America, and sixth in Andean
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Latin America in 1990, and first in all these regions in 2010. Risk factors for childhood
communicable disease had been largely replaced by those causing non-communicable
diseases in these regions by 2010, although household air pollution from solid fuels was still
an important risk factor in Andean Latin America in 2010.
One of the most notable findings was the effect of alcohol use in Eastern Europe, where it
accounts for almost a quarter of total disease burden. Other risk factors, such as high blood
pressure, tobacco smoking including second-hand smoke, high body-mass index, and dietary
risks, also feature prominently, underscoring the large underlying burden of cardiovascular
disease in the region.
In North America, Australasia, southern Latin America, and western Europe, the share of
disease burden attributable to tobacco smoking including second-hand smoke has fallen
slightly; it has stayed almost constant in central Europe and high-income Asia Pacific.
Tobacco smoking including second-hand smoke was still the leading risk factor in 2010 in
North America and western Europe. Important decreases in disease burden are evident for
high blood pressure and total cholesterol in North America, Australasia, and western
Europe. High blood pressure is a leading risk for health in high-income Asia Pacific
(accounting for 8·5% [95% UI 7·1–10·1] of disease burden) and central Europe (18·9%
[16·8–20·8]); evidence from individual-level trials of salt and blood pressure and from cross-
population studies indicates that this result is likely to be driven partly by high salt
consumption in these regions.94,158 Falls in disease burden attributable to tobacco smoking
including second-hand smoke, high blood pressure, and high total cholesterol in high-
income regions have been partly offset by the increasing burden caused by high body-mass
index. In southern Latin America, high body-mass index accounted for almost 10% of
overall disease burden in 2010, and is the leading risk factor in southern Latin America and
Australasia.
Figure 6 summarises these regional patterns, in relation to the proportion of regional burden
and attributable DALYs per 1000 people. Regions in figure 6 are ordered by mean age of
death, a marker of the epidemiological transition. Figure 6 shows the clear transition away
from risk factors for childhood communicable disease towards risk factors for non-
communicable disease, with increasing mean age at death. This change is apparent from the
decrease in burden of disease attributable to undernutrition and unimproved water and
sanitation, with increased mean age at death, especially when the effect of risks is assessed
by DALYs per 1000 people (figure 6C, D). A clear general shift occurs towards a larger
proportion of overall burden arising from risk factors for non-communicable diseases,
particularly metabolic risks and dietary risk factors (figure 6A, B). However, the absolute
burden of risk factors for non-communicable disease does not increase with increasing mean
age at death. Rather, its magnitude is lower in high-income regions than in sub-Saharan
Africa and south Asia (figure 6C, D), showing the double burden of communicable and non-
communicable disease in regions early in the epidemiological transition.
Some risk factors deviated from the pattern of the proportional burden (percent of region-
specifc DALYs attributable to a risk factor) being closely associated with epidemiological
and demographic transition (shift from communicable to non-communicable disease with
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increasing mean age of death). The proportion of DALYs attributable to tobacco smoking
including second-hand smoke was largest in North America—where smoking among
women has generally been prevalent for a long time—and central and eastern Europe.
Central and eastern Europe and central Asia also had the largest proportion of disease
burden attributable to risk factors with large effects on cardiovascular diseases, which are
disproportionately high in these regions. Exposure to particulate matter from household and
ambient sources had the most varied pattern with respect to the epidemiological transition,
partly because of the heterogeneous pattern of exposure and the effects on both children and
adult causes of ill health. Household air pollution from solid fuels accounted for a large
proportion of disease burden in central, eastern, and western sub-Saharan Africa and it is a
leading risk factor in some Asian regions and Oceania. In central and east Asia in 2010,
ambient particulate matter pollution surpassed household air pollution in terms of its burden.
Discussion
The results of GBD 2010 suggest that the contributions of risk factors to regional and global
burden of diseases and injuries has shifted substantially between 1990, and 2010, from risk
factors that mainly cause communicable diseases in children to risk factors that mainly cause
non-communicable diseases in adults. The proportion of overall disease burden attributable
to childhood underweight— the leading risk factor worldwide in 1990—had more than
halved by 2010, making childhood underweight the eighth risk worldwide, behind six
behavioural and physiological risks, and household air pollution from solid fuels. Other risks
for child mortality, such as nonexclusive and discontinued breastfeeding, micronutrient
deficiencies, and unimproved water and sanitation, have also fallen. However, child and
maternal undernutrition risks collectively still account for almost 7% of disease burden in
2010, with unimproved water and sanitation accounting for almost 1%. Of the non-
communicable disease risks, high blood pressure, high body-mass index, high fasting
plasma glucose, alcohol use, and dietary risks have increased in relative importance. This
overall shift has arisen from a combintion of the ageing population, substantial achievements
in lowering mortality of children aged younger than 5 years, and changes in risk factor
exposure.
These broad global patterns mask enormous regional variation in risks to health. In sub-
Saharan Africa, risks such as childhood underweight, household air pollution from solid
fuels, and suboptimal breastfeeding continue to cause a disproportionate amount of health
burden, despite decreasing. The shift to risk factors for non-communicable disease was clear
in east Asia, North Africa and Middle East, and Latin America. This regional heterogeneity
underestimates even greater differences in exposure to, and health effects of, risk factors in
national and subnational populations. These differences should be further elucidated in
country-specific analyses using the framework and methods reported here.
Our analysis shows the large burden of disease attributable to primary and secondary
tobacco smoking and to particulate matter pollution in household and ambient environments.
The magnitude of disease burden from particulate matter is substantially higher than
estimated in previous comparative risk assessment analyses. For example, ambient
particulate matter pollution was estimated in the previous comparative risk assessment7 to
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account for 0·4% of DALYs in 2000 compared with 3·1% in GBD 2010 based on
interpolating our 1990 and 2005 results; for household air pollution from solid fuels the
comparison is 2·7% in the previous comparative risk assessment versus 5·3% based on GBD
2010.
Several reasons could account for this difference. First, accumulation of evidence from
epidemiological studies about diseases caused by particulate matter, and the use of an
integrated exposure–response curve, has led to the inclusion of more outcomes than before.
For example, health effects for ischaemic heart disease and stroke were not previously
included for household air pollution from solid fuels, and lung cancer was included for coal
smoke only. Second, the previous assessment of ambient particulate matter pollution was
restricted to medium and large cities. High-resolution satellite data and chemical transport
models have enabled us to quantify exposure and burden for all rural and urban populations.
Third, the previous assessment of ambient particulate matter pollution did not include
additional increments of risk above a concentration of 50 µg/m3 for PM2·5, because of the
narrow range of ambient particulate matter pollution levels reported in epidemiological
studies. The use of an integrated exposure–response curve enabled us to estimate a
continuous risk function across the full range of particulate matter concentrations, which
covers the very high concentrations of ambient particulate matter exposure measured in, for
example, parts of east Asia.
Our integrated exposure–response curve, however, does not address how different sources of
particulate matter interact in terms of effects and overlapping exposures. Studies124,159,160
have reported broadly similar effect sizes for ambient particulate matter by smoking status
(never, former, and current smokers). Other evidence161 shows that the effects diminish with
increasing exposure for active smoking, a pattern incorporated into our exposure– response
curves. We applied the effects of ambient particulate matter to both smokers and non-
smokers alike to be consistent with the epidemiological evidence that emphasises
independent effects of ambient particulate matter. The reasons for the independent effects of
different sources of particulate matter should be further investigated. They might include
different compositions of particulate matter by source, or different time patterns of
exposure162—eg, exposure to particulate matter from active smoking is characterised by
episodic, high doses whereas exposure to ambient particulate matter is more constant over
time.
These limitations aside, the large attributable burden documented in our analysis represents
a major shift in our understanding of disease burden arising from particulate matter and
emphasises the need to design alternative fuels for household cooking and heating,163
implement more stringent regulation of vehicle and industrial emissions,164–166 reduce
agricultural burning or land clearing by fire,167 and curb and reverse deforestation and
desertification to reduce ambient particulate matter from dust.168–171 A large share of
ambient particulate matter in Asia and sub-Saharan Africa originates from solid fuel.172,173
Therefore the two exposures are related, and alternative cooking and heating fuels would
have benefits for people who currently use solid fuels as well as those who do not, but live
in the same community.173
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Unimproved water and unimproved sanitation together accounted for 0·9% of DALYs in
2010, compared with 2·1% in 1990. These proportions are substantially smaller than the
6·8% for 1990, and 3·7% for 2000, estimated in previous GBD studies for water, sanitation,
and hygiene combined.3,7 The relatively small burden estimated for 2010 is partly related to
decreases in diarrhoeal disease mortality since 1990, and partly to differences in the
distributions of deaths by underlying cause of death. We have also done an updated meta-
analysis of quasi experimental and experimental studies. Historical demographic analyses
suggest that the introduction of piped water into cities in the late 19th and early 20th
centuries had a large beneficial effect on mortality.174 However, our re-analysis both when
restricted to experimental studies and when also including quasi experimental studies did not
detect a significantly improved effect of household water connections over improved water
sources. Similarly, we did not find a significantly improved effect of water quality
interventions, consistent with the findings reported by Cairncross and colleagues,128 which
showed that masked point-of-use water quality interventions did not have a significant effect
on self-reported diarrhoea. As a result of this reassessment, we restricted our analysis to
improved water and improved sanitation compared with unimproved sources following the
MDG definitions. However, the interventions used in previous studies might not have
achieved their full efficacy because of the quality of implementation. The real burden from
water and sanitation could therefore be underestimated if well-implemented household
connect ions and water quality interventions have a larger effect than improved water
sources alone, and if the combination of poor water and sanitation has a larger effect than a
sample interaction of individual effects. More definitive epidemiological evidence is needed
to assess the effects of low quality versus high quality water, household connections versus
improved water sources, and exposure based on travel time to water source.175 Also, we
could not include an assessment of personal hygiene because of the paucity of national
exposure data.
Our findings on the burden of micronutrients are also substantially smaller than those in the
previous comparative risk assessment for 2000 and in estimates for 2004 by Black and
colleagues10 in The Lancet's Maternal and Child Undernutrition Series. For example, Black
and colleagues estimated 668 000 deaths caused by vitamin A deficiency in 2004; we
estimated a quarter (168 000 deaths) for 2005; for zinc deficiency, the differences are
similarly large (453 000 vs 120 000). These differences stem from many sources. First, the
estimates of Black and colleagues were based on 10·3 million child deaths worldwide, itself
based on WHO estimates of global child deaths for 2004. This estimate is substantially
larger than those reported by UNICEF176 and the Institute for Health Metrics and
Evaluation177 at the time of Black and colleagues' publication.
Large differences also exist for cause-specific mortality, especially in relation to diarrhoea
and lower respiratory tract infections (which can be affected by both of these risks) versus
malaria (which is not).176 The estimates also differ because of differences in the availability
and interpretation of epidemiological evidence for disease outcomes and effect sizes.
Maternal mortality and malaria as outcomes of vitamin A deficiency were included in the
2000 comparative risk assessment but they were not included in the present report because
recent epidemiological evidence did not show a significant effect of supplementation on
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these outcomes. Furthermore, we excluded neonatal vitamin A deficiency since it is the
subject of three ongoing randomised trials. The age at which the effects of zinc deficiency
begin was increased from birth in the 2000 comparative risk assessment, to 6 months in
2004,10 and to 12 months in the present analysis based on a reassessment of existing and
new supplementation trials. Furthermore, we quantified the proportion of the population
who are vitamin A or zinc deficient instead of classing whole countries as exposed or non-
exposed. The evolving epidemiology of exposure to micronutrient deficiency and the
subsequent health effects suggests a need to systematically reconsider most single nutrient
supplementation for children in preventive strategies to lower child mortality, as suggested
by the 2000 comparative risk assessment and later analyses. 10 Therapeutic zinc
supplementation in health-care settings is feasible, as is iron supplementation during
pregnancy.174–179 Our findings support the need for strengthened policy about promotion of
optimal breastfeeding practices and nutritional programmes that improve child growth. The
estimated number of child deaths caused by underweight has also changed substantially over
successive studies: in GBD 1990 it was estimated to be 5·9 million deaths in 1990,180 in the
comparative risk assessment study for 2000 as 3·7 million deaths,7 and 1·9 million deaths in
2004.10 In GBD 2010 we estimated 2·3 million deaths for 1990 and 0·9 million deaths for
2010.
The evolution of estimates for deaths caused by childhood under weight is because of
improvements in assessment of the population at risk. These improvements come from
systematic analysis of the available data on underweight, a major modification of RRs after
the change in the WHO standard in 2006, and differences in estimates of total and cause-
specific mortality. We have also assessed the burden attributable to childhood wasting and
childhood stunting. These analyses produce quite similar findings, for example, worldwide,
childhood wasting accounted for 0·7 million deaths in 2010, and childhood stunting for 0·9
million deaths, compared with 0·9 million deaths for childhood under weight (the effects of
these risks cannot be added).
The global burden of disease attributable to tobacco smoking including second-hand smoke
has changed little, with decreases in high-income regions offset by increases in regions such
as south east Asia and, to a lesser extent, east and south Asia. The burden attributable to
alcohol use has increased substantially in eastern Europe since 1990, mainly because of a
rise in the effects of heavy drinking on cardiovascular diseases.181 The high burden in
eastern Europe was also identified in the 2000 comparative risk assessment but the data for
patterns of alcohol consumption and their effects were weaker, whereas now they are
supported by more surveys and epidemiological studies.182 High blood pressure, high body-
mass index, and high fasting plasma glucose are leading risk factors for disease worldwide,
with blood pressure having large effects on population health in all regions, including low-
income regions in sub-Saharan Africa and south Asia. This finding is consistent with
previous comparative risk assessment analyses. The disease burden in south Asia and sub-
Saharan Africa, caused by increased blood pressure,70 has increased its absolute and relative
importance in risk factor rankings. The large burden of high blood pressure emphasises the
importance of implementing both population-wide and high-risk approaches to reduction of
blood pressure.183,184 The worldwide increase in body-mass index and blood glucose is of
particular concern in view of the absence of effective interventions.62,74 In contrast to these
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risks, the burden of high total cholesterol is lower than that estimated in the 2000
comparative risk assessment, because the effects on ischaemic stroke were negligible at old
ages when data from the Asia-Pacific Cohort Studies Collaboration and Prospective Studies
Collaboration were pooled,68,185 and because exposure has fallen in high-income
countries.67
A recent study estimated that 5·3 million deaths were attributable to physical inactivity in
2008.186 This number, which has been widely quoted and equated with the number of deaths
attributable to tobacco smoking,187 used effect sizes for all-cause mortality obtained from
cohorts of adults mainly from North America and Europe and applied these effects to deaths
at all ages. This approach not only assumes that the cause distribution is the same in all
populations, irrespective of region and age structure, but also extends the effects to people
younger than those in the cohort study, including to infants and children. In other words, a
proportion of deaths from maternal causes, neonatal causes, and children’s infectious
diseases and HIV were attributed to physical inactivity.186 The prevalence of inactivity also
included people who had sedentary patterns as well as those in the low (insufficient) activity
group. By contrast, our approach—calculating attributable burden by cause and age group,
and accounting for exposure in four categories—estimated substantially fewer attributable
deaths: 3·2 million (2·7 million to 3·7 million) in 2010, 56% of what we attribute to tobacco
smoking when second-hand smoke is excluded. This discrepancy shows the importance of
comparable risk factor assessments and the importance of estimation of attributable burden
taking into account differences in underlying disease and injury patterns across populations.
We have expanded the set of components of diet included from a combined category of
fruits and vegetables in the 2000 comparative risk assessment to 15 components in GBD
2010; together these dietary risk factors account for a tenth of global disease burden. Of the
dietary risk factors, the aetiological effect sizes for sodium, polyunsaturated fatty acids
replacing saturated fatty acids, and seafood omega-3 fatty acids were informed fully (for
sodium) or partly by randomised controlled trials. Disease burden attributable to diet high in
sodium was a third of that for high blood pressure. The theoretical-minimum-risk exposure
distribution was selected on the basis of values reported in randomised trials; studies of
populations with low prevalence of cardiovascular disease suggest that benefits are likely to
continue to lower levels.158
The large attributable burden for dietary risk factors such as diets low in fruits, vegetables,
whole grains, nuts and seeds, and seafood omega-3 fatty acids might surprise some readers.
The large burden is caused by both high exposure—eg, low intake of fruits in many regions
—and large effect sizes. We did supplementary analyses using information from studies of
dietary patterns and randomised controlled feeding studies to examine the robustness of the
effect sizes used in GBD 2010. The findings of these supplementary analyses were
consistent with those from the meta-analyses of single risk factors. However, we stress that
these results should still be interpreted with caution, particularly because of the debate
surrounding the effects of seafood omega-3 fatty acids.143,188 Empirical assessments show
that the pooled effect of risks and interventions trends towards a null result over time189,190
and this pattern could apply to seafood omega-3 fatty acids since the earlier, primarily
observational effect sizes tended to show a larger effect than did the more recent randomised
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controlled trials. Because the difference between results of observational studies and
randomised controlled trials is not statistically significant we have quantified the attributable
burden by use of the combined effect size. However, the validity of this approach could
change as new evidence accumulates. Also, evidence from randomised controlled trials does
not exist for several of the dietary components with a large attributable burden—fruits,
vegetables, and nuts and seeds—although, as previously noted, evidence from randomised
controlled trials does exist for inter mediate outcomes. Further work is needed to confirm the
effect size of dietary components and to establish to what degree the benefits continue,
preferably through intervention studies of fatal and non-fatal events.
The extended analysis of components of diet does not include saturated fat beyond its
replacement by polyunsaturated fats. Ecological studies suggest that saturated fat intake is a
significant risk factor for mortality from ischaemic heart disease.191 However, observational
studies indicate that there might be no benefits if saturated fat reduction is associated with an
increase in carbohydrates,91 which is also supported by the absence of benefits from a low
fat diet in the Women’s Health Initiative.192 Together with data for seafood omega-3 fatty
acids, these findings show the complexity of the relation between dietary fat and health and
suggest that the traditional health education message focused on lowering saturated fat alone
needs to be expanded greatly to encompass several other key components of diet, including
increased consumption of healthy foods that are presently missing from most diets.
The strengths of our study include a more comprehensive set of risk factors than any
previous global or national analysis, consistent analyses in 1990, and 2010, which enables
assessment of changes in risk factor burden, the incorporation of substantially more data for
risk-factor exposure, improved methods to deal with missing and incomparable data, strong
emphasis on comparability of methods related to exposure, disease outcomes, and effect
sizes, and use of theoretical-minimum-risk exposure distribution as the consistent alternative
exposure distribution with which current exposures are compared.
Like all population-based analysis, our study also has some limitations. First, despite the
massive improvement in the availability of exposure data and methods, exposure estimates
for many risk factors are affected by data limitations, especially for 2010, since fewer data
could be included. This limitation will become even more salient in applications of our
methods to individual countries and shows the importance of surveillance of national risk
factors as a crucial component of national health information systems. More importantly, for
some risk factors we have less direct measures of exposure than for others. For example, for
household air pollution from solid fuels we measured exposure on the basis of household
fuel use rather than personal exposure to particulate matter; for other risks, such as blood
pressure, we have direct biological measurements of exposure.
Second, the presence of residual confounding in the estimates of effect sizes cannot be
definitively ruled out, particularly for those without evidence from intervention studies,
either because they have not yet been done or the risk is not amenable to intervention. For
example, no large-scale trials have been done of interventions for high body-mass index that
measured cause-specific deaths although effects on disease incidence have been investigated
in trials.193 Observational studies of the effect sizes for body-mass index have controlled for
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some potential confounders.75–77 As noted, the pooled effect of risks and interventions
trends towards the null result over time;189,190 the implication being that risks for which
only a few studies have been done might have their effect overestimated compared with
risks for which a large body of evidence exists.
Third, with the exception of risk factors for which much evidence has been accumulated
across diverse populations and age groups, such as the metabolic risks, uncertainty remains
as to the extent to which effect sizes are generalisable to different populations. Similarly, the
large body of epidemiological evidence for cardiovascular risk factors shows a relation
between age and the effect size of risk factors for cardiovascular disease. Such age-related
changes might be present for other outcomes. Fourth, we have combined epidemiological
evidence for effect sizes using studies across different periods, which could mask underlying
temporal changes in risk; no data presently exist to enable an examination of the extent to
which effect sizes might change over time.
Fifth, we have excluded risks for which insufficient information exists to enable estimation
of exposure, or for which the evidence of effect sizes is scarce. This approach excludes
several risk–outcome pairs that have been previously included in global and regional
assessments of risk factor attributable burden, such as unsafe sex and global climate change.
Unsafe sexual practices were included in the 2000 comparative risk assessment but we
excluded it because of the absence of robust estimates of exposure or available approaches
to determine the proportion of HIV infection that is attributable to unsafe sexual practices by
country over time. If quantifiable, unsafe sexual practices would probably account for a
large fraction of global health burden; the direct burden of HIV is 3·3% of DALYs in 2010;
other sexually transmitted infections account for 0·4% of DALYs. Similarly, we have been
unable to control for confounding in observational studies of late initiation of breastfeeding,
which is associated with an increased risk of neonatal mortality. Infants who might too ill or
weak to breastfeed are more likely to die. In our analysis, we could not assess low
birthweight as an outcome for maternal iron deficiency, despite evidence from random ised
trials. Similarly, we could not assess low birthweight as an outcome for maternal alcohol
use. Low birthweight was not a disease outcome in GBD 2010 but is associated with an
increased risk of neonatal mortality. We excluded several other risk–outcome pairs that had
insufficient evidence to estimate effect sizes or that had substantial potential of residual
confounding— eg, the effect of addictive drugs (cannabis, amphetamines, and opioids) on
unintentional and intentional injuries; or the effects of intimate partner violence, on HIV or
other sexually transmitted infections.
Sixth, we included few risks that affected three of the leading communicable diseases—
HIV/AIDs, tuberculosis, and malaria (beyond deaths in childhood). Overall, we have not
included risks for 126 of the 241 most detailed causes included in the GBD, which account
for 26·3% of global disease health burden. This shortcoming emphasises the need for a more
deliberate research focus to identify and quantify risk factors for the outcomes for which
there are presently no risks or few large risks.
Seventh, we have quantified the attributable burden of risk factors, holding all other
independent factors constant. For clusters of risk factors we have approximated the joint
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effects, assuming that risk factors within each cluster are independent. A more accurate
quantification of the joint effects of multiple risk factors is an important area for future
research. Finally, it is important to stress that the size of the attributable risk factor burden
does not equal priority for action since prioritisation also depends on availability, cost, and
effectiveness of inter vention strategies to reduce exposures to these risks.
Public policy to improve the health of populations will be more effective if it addresses the
major causes of disease burden. Even small reductions of population exposure to large risks
will yield substantial health gains.194 The principal advantage of doing a comprehensive and
comparable scientific assessment of disease burden caused by different risk factors is that it
provides the evidence base for informing discussion about policy. Coupled with evidence of
their present burden, most of the leading risk factors, except high body-mass index and high
fasting plasma glucose, have decreased in at least some regions and countries, showing that
substantial reduction of their effect through targeted prevention strategies is feasible. If
predictions about huge increases in disease burden worldwide are to be proved wrong, then
countries, with appropriate global public health leadership, must urgently implement
measures to control exposure to leading hazards, particularly risks for non-communicable
diseases.
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Panel: The World Cancer Research Fund grading system118
Convincing evidence
Evidence based on epidemiological studies showing consistent associations between
exposure and disease, with little or no evidence to the contrary. The available evidence is
based on a substantial number of studies including prospective observational studies and
where relevant, randomised controlled trials of sufficient size, duration, and quality
showing consistent effects. The association should be biologically plausible.
Probable evidence
Evidence based on epidemiological studies showing fairly consistent associations
between exposure and disease, but for which there are perceived shortcomings in the
available evidence or some evidence to the contrary, which precludes a more definite
judgment. Shortcomings in the evidence may be any of the following: insufficient
duration of trials (or studies); insufficient trials (or studies) available; inadequate sample
sizes; or incomplete follow-up. Laboratory evidence is usually supportive. The
association should be biologically plausible.
Possible evidence
Evidence based mainly on findings from case-control and cross-sectional studies.
Insufficient randomised controlled trials, observational studies, or non-randomised
controlled trials are available. Evidence based on non-epidemiological studies, such as
clinical and laboratory investigations, is supportive. More trials are needed to support the
tentative associations, which should be biologically plausible.
Insufficient evidence
Evidence based on findings of a few studies which are suggestive, but insufficient to
establish an association between exposure and disease. Little or no evidence is available
from randomised controlled trials. More well-designed research is needed to support the
tentative associations.
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Figure 1. Burden of disease attributable to 20 leading risk factors in 1990, expressed as a
percentage of global disability-adjusted life-years
For men (A), women (B), and both sexes (C).
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Figure 2. Burden of disease attributable to 20 leading risk factors in 2010, expressed as a
percentage of global disability-adjusted life-years
For men (A), women (B), and both sexes (C).
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Figure 3. Global risk factor ranks with 95% UI for all ages and sexes combined in 1990, and
2010, and percentage change
PM=particulate matter. UI=uncertainty interval. SHS=second-hand smoke. An interactive
version of this figure is available online at http://healthmetricsandevaluation.org/gbd/
visualizations/regional.
Lim et al. Page 47






















Figure 4. 95% uncertainty intervals for risk factors ranked by global attributable disability-
adjusted life-years, 2010
An interactive version of this figure is available online at http://
healthmetricsandevaluation.org/gbd/visualizations/regional
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Figure 5. Risk factors ranked by attributable burden of disease, 2010
Regions are ordered by mean life expectancy. No data=attributable disability-adjusted life-
years were not quantified.
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Figure 6. Attributable burden for each risk factor
As percentage of disability-adjusted life-years in 1990 (A), and 2010 (B), and as disability-
adjusted life-years per 1000 people in 1990 (C), and 2010 (D). Regions ordered by mean life
expectancy. Burden of disease attributable to individual risk factors are shown sequentially
for ease of presentation. In reality, the burden attributable to different risks overlaps because
of multicausality and because the effects of some risk factors are partly mediated through
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other, more proximal, risks. An interactive version of this figure is available online at http://
healthmetricsandevaluation.org/gbd/visualizations/regional.
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Lim et al. Page 64
Table 2





  High blood pressure 53%
  High total cholesterol 29%
  High body-mass index 23%
  High fasting plasma glucose 16%
Alcohol use 33%
Tobacco smoking, including second-hand smoke 31%
Dietary risk factors and physical inactivity
  Diet low in nuts and seeds 40%
  Physical inactivity and low physical activity 31%
  Diet low in fruits 30%
  Diet low in seafood omega-3 fatty acids 22%
  Diet low in whole grains 17%
  Diet high in sodium 17%
  Diet high in processed meat 13%
  Diet low in vegetables 12%
  Diet low in fibre 11%
  Diet low in polyunsaturated fatty acids 9%
  Diet high in trans fatty acids 9%
  Diet high in sugar-sweetened beverages 2%
Air pollution
  Ambient particulate matter pollution 22%
  Household air pollution from solid fuels 18%
Other environmental risks
  Lead exposure 4%
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